中文 | English
Return
Total: 392 , 1/40
Show Home Prev Next End page: GO
Author:(Shi-jun GAO)

1.Relationship between Hybrid Muscle Creatine Kinase Isozyme and Changes of Bilirubin Level in Neonates with Hypoxic - Ischemic Encephalopathy

chao, GAO ; jun, WANG ; shi-xing, MIAO

Journal of Applied Clinical Pediatrics 1992;0(06):-

2.Significance of the high-risk human papilloma virus detection in the screening and diagnosis of cervical lesions

Na GAO ; Jun ZHENG ; Hong SHI ; Tao WU

Chinese Journal of Postgraduates of Medicine 2012;35(21):7-10

3.Indoleamine 2,3-dioxygenase and forkhead boxP3 on immune tolerance of gallbladder carcinoma cells

Jian GAO ; Xingyuan JIAO ; Peng ZHANG ; Jun DU ; Jingsen SHI

Chinese Journal of Hepatobiliary Surgery 2012;18(4):252-255

4.Suppression of insulin-like growth factor-1 receptor by RNA interference inhibits cell growth in vitro and induces chemosensitization of HO8910PM cell to cisplatin

Hua GAO ; Jun SHI ; Shengfang GE ; Wen DI

Chinese Journal of Obstetrics and Gynecology 2008;43(1):45-49

6.Selective Salpingography and Recanulization Using a Self-Made Coaxial Catheter Set for Fallopian Tube Obstruction

Jinhe GUO ; Gao-Jun TENG ; Shi-Cheng HE ;

Journal of Interventional Radiology 1994;0(02):-

7.Study on Quality Standard for Compound Heishen Pills

Jin ZHANG ; Hongda MA ; Jun GAO ; Bei HU ; Guobing SHI

China Pharmacist 2014;(5):716-718

9.Intraductal radiofrequency ablation for malignant biliary strictures

Bing HU ; Jun WU ; Daojian GAO ; Yamin PAN ; Zhimei SHI ; Hui HUANG ; Shuping WANG ; Rui LU

Chinese Journal of Digestive Endoscopy 2012;29(9):487-490

10.Suberoylanilide hydroxamic acid (SAHA) suppresses JAK/STAT1 signal pathway to down-regulate the expression of indoleamine 2, 3-dioxygenuse in gallbladder carcinoma cells

Peng ZHANG ; Guanmin JIANG ; Jian GAO ; Lingling LI ; Jun DU ; Xingyuan JIAO ; Jingsen SHI

Chinese Journal of Hepatobiliary Surgery 2011;17(10):833-837

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 392 , 1/40 Show Home Prev Next End page: GO